![](/img/cover-not-exists.png)
PDB52 TYPE-2 DIABETES MODELS THAT DO NOT ACCOUNT FOR MICROVASCULAR DISEASE SCREENING RATESAND IMPORTANT CONCOMITANT MEDICATION USE MAY LEAD TO SUBSTANTIAL MISREPRESENTATION OF THE COST-EFFECTIVENESS OF NEW MEDICATIONS
AJ Palmer, WJ Valentine, ME Minshall, S RozeVolume:
8
Year:
2005
Language:
english
DOI:
10.1016/s1098-3015(10)67670-x
File:
PDF, 59 KB
english, 2005